3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Rectal Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Motor Activity
2
Leukemia, Myeloid, Acute
2
Breast Neoplasms
2
Vomiting
1
Pathologic Processes
1
Neoplasms
1
Nausea
1
Malnutrition
1
Lymphatic Metastasis
1
Lung Neoplasms
1
Liver Diseases
1
Hematologic Neoplasms
1
Gastrointestinal Neoplasms
1
Frailty
1
Carcinoma, Hepatocellular
1
Breast Cancer Female
1
Interventions
Bevacizumab
52
Cetuximab
46
Fluorouracil
45
Oxaliplatin
39
Leucovorin
37
pembrolizumab
32
Specimen Handling
28
Irinotecan
25
Biopsy
17
Magnetic Resonance Spectroscopy
16
Nivolumab
15
HMPL-013
14
Folfox protocol
14
Capecitabine
14
trifluridine tipiracil drug combination
12
Panitumumab
12
Gemcitabine
12
Cisplatin
11
Carboplatin
10
balstilimab
9
IFL protocol
9
Trifluridine
8
Standard of Care
8
Pemetrexed
8
Early Intervention, Educational
8
130-nm albumin-bound paclitaxel
8
encorafenib
7
Radiotherapy
7
Paclitaxel
7
Educational Status
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Colorectal Neoplasms
×
Control Groups
×
90 days
×
Clear all
No trials found.